Jennifer Marie Tetzlaff
#114,324
Most Influential Person Now
Jennifer Marie Tetzlaff's AcademicInfluence.com Rankings
Jennifer Marie Tetzlaffphilosophy Degrees
Philosophy
#4909
World Rank
#7584
Historical Rank
Logic
#2273
World Rank
#3232
Historical Rank
Download Badge
Philosophy
Why Is Jennifer Marie Tetzlaff Influential?
(Suggest an Edit or Addition)Jennifer Marie Tetzlaff's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. (2010) (41666)
- Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement (2009) (32445)
- Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement (2009) (24017)
- The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration (2009) (20340)
- Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement (2009) (19605)
- The PRISMA 2020 statement: an updated guideline for reporting systematic reviews (2021) (17108)
- The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration (2009) (13688)
- Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. (2009) (11776)
- The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. (2009) (7631)
- Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials (2011) (4355)
- The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. (2009) (3700)
- SPIRIT 2013 statement: defining standard protocol items for clinical trials. (2013) (3679)
- Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. (2009) (3428)
- SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials (2013) (3035)
- PRISMA statement. (2011) (2896)
- Reprint--preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. (2009) (2834)
- PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews (2020) (2160)
- The PRISMA 2020 statement: an updated guideline for reporting systematic reviews (2021) (1336)
- Epidemiology and Reporting Characteristics of Systematic Reviews (2007) (796)
- The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. (2021) (788)
- SPIRIT 2013 Statement: defining standard protocol items for clinical trials. (2015) (688)
- Updating guidance for reporting systematic reviews: development of the PRISMA 2020 statement. (2021) (662)
- The PRISMA 2020 statement: An updated guideline for reporting systematic reviews (2021) (617)
- The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. (2020) (562)
- Epidemiology and Reporting Characteristics of Systematic Reviews of Biomedical Research: A Cross-Sectional Study (2016) (452)
- SPIRIT 2013: new guidance for content of clinical trial protocols (2013) (206)
- The art and science of knowledge synthesis. (2011) (157)
- Non-Cochrane vs. Cochrane reviews were twice as likely to have positive conclusion statements: cross-sectional study. (2009) (76)
- Few systematic reviews exist documenting the extent of bias: a systematic review. (2008) (75)
- No consensus exists on search reporting methods for systematic reviews. (2008) (59)
- Guidelines for randomized clinical trial protocol content: a systematic review (2012) (58)
- Developing a guideline for clinical trial protocol content: Delphi consensus survey (2012) (53)
- Precision of healthcare systematic review searches in a cross‐sectional sample (2011) (50)
- Error rates of human reviewers during abstract screening in systematic reviews (2020) (35)
- Knowledge Synthesis (2017) (31)
- Barriers to metered-dose inhaler/spacer use in Canadian pediatric emergency departments: a national survey. (2006) (29)
- Survey of the Reporting Characteristics of Systematic Reviews in Rehabilitation (2013) (29)
- Comparative effectiveness of monotherapies and combination therapies for patients with hypertension: protocol for a systematic review with network meta-analyses (2013) (18)
- Interactions of commonly used dietary supplements with cardiovascular drugs: a systematic review (2012) (17)
- Updating guidance for reporting systematic reviews: development of the PRISMA 2020 statement (2020) (14)
- PNS154 THE PRISMA 2020 STATEMENT: DEVELOPMENT OF AND KEY CHANGES IN AN UPDATED GUIDELINE FOR REPORTING SYSTEMATIC REVIEWS AND META-ANALYSES (2020) (13)
- Dietary Supplements in Adults Taking Cardiovascular Drugs (2012) (5)
- Checking whether there is an increased risk of post-transplant lymphoproliferative disorder and other cancers with specific modern immunosuppression regimens in renal transplantation: Protocol for a network meta-analysis of randomized and observational studies (2014) (5)
- Drug Safety and Effectiveness Network Report: A Systematic Review with Network Meta-Analyses and Economic Evaluation Comparing Therapies for Hypertension in Non-Diabetic Patients (2014) (3)
- 2.1. Knowledge synthesis (2013) (1)
- Developing an evidence-based reporting guideline for randomized controlled trial protocols: The SPIRIT Initiative (2010) (1)
- Data Extraction Forms (2012) (0)
- PNS319 USE OF ARTIFICIAL INTELLIGENCE WITH DISTILLERSR SOFTWARE AS A REVIEWER FOR A SYSTEMATIC LITERATURE REVIEW OF COST-EFFECTIVENESS MODELS (2019) (0)
- Table 27, Summary and strength of evidence for cardiovascular drugs with or without G. biloba—Intermediate outcomes (2012) (0)
- Figure 19, Forest plot of serious adverse events with statins, with or without omega-3 fatty acids (2012) (0)
- PNS306 USE OF ARTIFICIAL INTELLIGENCE WITH DISTILLERSR SOFTWARE AS A REVIEWER FOR A SYSTEMATIC LITERATURE REVIEW OF RANDOMIZED CONTROLLED TRIALS (2019) (0)
- PNS15 PRAGMATIC ARTIFICIAL INTELLIGENCE-BASED REFERENCE SCREENING IN SYSTEMATIC REVEIWS. ARE TWO ROBOTS BETTER THAN ONE? (2019) (0)
- AI4 CAN WE DECREASE THE SCREENING BURDEN IN SYSTEMATIC REVIEWS? PERFORMANCE OF TWO NATURAL LANGUAGE PROCESSORS TO EXCLUDE RECORDS (2020) (0)
This paper list is powered by the following services:
